Therapeuticsmd, Inc.
A maker of women's health medicines, it developed the brands Annovera, a vaginal contraceptive, and BIJUVA and IMVEXXY, hormone therapies for menopause. Founded in 2008 in Boca Raton, Florida, after a medical-device entrepreneur and an obstetrician-gynecologist met in their neighborhood, the name pairs "therapeutics" with the co-founder's medical degree. The firm has since licensed its products to partners and now earns royalties on their sales.
Granted 877.2K
Granted 78.3K · Bought 2.8K · Sold 19.1K
Granted 8.5K · Bought 5.3K
Granted 8.5K · Bought 8.7K
Granted 8.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rosen David Efraim +1 co-filer10% owner, Director, 10% owner, See Remarks. · 1 transaction | +42.4% | 2.95Mas of Nov 2023 | 877.2K | — | — |
| Walker Marlan DChief Executive Officer · 10 transactions | +534% | 73.6Kas of Apr 2025 | 78.3K | 2.8K | 19.1K |
| Collins Cooper C.Director · 3 transactions | +29.5% | 60.5Kas of Feb 2025 | 8.5K | 5.3K | — |
| Thompson Tommy GDirector · 3 transactions | +84.9% | 37.5K | 8.5K | 8.7K | — |
| Naughton Gail KDirector · 1 transaction | — | 8.5Kas of Feb 2025 | 8.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -2.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.